1-7 of 7
W. Joost Lesterhuis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Pathways: The Immunogenic Effects of Platinum-Based Chemotherapeutics

Stanleyson V. Hato, Andrea Khong, I. Jolanda M. de Vries, W. Joost Lesterhuis
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (11): 2831–2837.
https://doi.org/10.1158/1078-0432.CCR-13-3141
Published: 29 May 2014
View article titled, Molecular Pathways: The Immunogenic Effects of Platinum-Based Chemotherapeutics
Open the PDF for Molecular Pathways: The Immunogenic Effects of Platinum-Based Chemotherapeutics in another window
Journal Articles

Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells

Erik H.J.G. Aarntzen, Mangala Srinivas, Fernando Bonetto, Luis J. Cruz, Pauline Verdijk, Gerty Schreibelt, Mandy van de Rakt, W. Joost Lesterhuis, Maichel van Riel, Cornelius J.A. Punt, Gosse J. Adema, Arend Heerschap, Carl G. Figdor, Wim J. Oyen, I. Jolanda M. de Vries
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (6): 1525–1533.
https://doi.org/10.1158/1078-0432.CCR-12-1879
Published: 14 March 2013
View article titled, Targeting of <sup>111</sup>In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells
Open the PDF for Targeting of <sup>111</sup>In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells in another window
Includes: Supplementary data
Journal Articles

Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients

Erik H. J. G. Aarntzen, Gerty Schreibelt, Kalijn Bol, W. Joost Lesterhuis, Alexandra J. Croockewit, Johannes H. W. de Wilt, Michelle M. van Rossum, Willeke A. M. Blokx, Joannes F. M. Jacobs, Tjitske Duiveman-de Boer, Danita H. Schuurhuis, Roel Mus, Kris Thielemans, I. Jolanda M. de Vries, Carl G. Figdor, Cornelis J. A. Punt, Gosse J. Adema
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5460–5470.
https://doi.org/10.1158/1078-0432.CCR-11-3368
Published: 30 September 2012
View article titled, Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4<sup>+</sup> and CD8<sup>+</sup> T Cells Responses in Stage III and IV Melanoma Patients
Open the PDF for Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4<sup>+</sup> and CD8<sup>+</sup> T Cells Responses in Stage III and IV Melanoma Patients in another window
Includes: Supplementary data
Journal Articles

Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients

W. Joost Lesterhuis, I. Jolanda M. de Vries, Gerty Schreibelt, Annechien J.A. Lambeck, Erik H.J.G. Aarntzen, Joannes F.M. Jacobs, Nicole M. Scharenborg, Mandy W.M.M. van de Rakt, Annemiek J. de Boer, Sandra Croockewit, Michelle M. van Rossum, Roel Mus, Wim J.G. Oyen, Otto C. Boerman, Sophie Lucas, Gosse J. Adema, Cornelis J.A. Punt, Carl G. Figdor
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (17): 5725–5735.
https://doi.org/10.1158/1078-0432.CCR-11-1261
Published: 01 September 2011
View article titled, Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients
Open the PDF for Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients in another window
Includes: Supplementary data
Journal Articles

Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients

Joannes F.M. Jacobs, Cornelis J.A. Punt, W. Joost Lesterhuis, Roger P.M. Sutmuller, H. Mary-lène H. Brouwer, Nicole M. Scharenborg, Ina S. Klasen, Luuk B. Hilbrands, Carl G. Figdor, I. Jolanda M. de Vries, Gosse J. Adema
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (20): 5067–5078.
https://doi.org/10.1158/1078-0432.CCR-10-1757
Published: 13 October 2010
View article titled, Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients
Open the PDF for Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients in another window
Journal Articles

Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients

Pauline Verdijk, Erik H.J.G. Aarntzen, W. Joost Lesterhuis, A.C. Inge Boullart, Ellemieke Kok, Michelle M. van Rossum, Simon Strijk, Femke Eijckeler, Johannes J. Bonenkamp, Joannes F.M. Jacobs, Willeke Blokx, J. Han J.M. vanKrieken, Irma Joosten, Otto C. Boerman, Wim J.G. Oyen, Gosse Adema, Cornelis J.A. Punt, Carl G. Figdor, I. Jolanda M. de Vries
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (7): 2531–2540.
https://doi.org/10.1158/1078-0432.CCR-08-2729
Published: 01 April 2009
View article titled, Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients
Open the PDF for Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients in another window
Journal Articles

Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients

I. Jolanda M. de Vries, W. Joost Lesterhuis, Nicole M. Scharenborg, Linda P. H. Engelen, Dirk J. Ruiter, Marie-Jeanne P. Gerritsen, Sandra Croockewit, Cedrik M. Britten, Ruurd Torensma, Gosse J. Adema, Carl G. Figdor, Cornelis J. A. Punt
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5091–5100.
Published: 12 November 2003
View article titled, Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients
Open the PDF for Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients in another window